Table 3.
Predictive performance of the model applied to the intercontinental patients’ cohort with corresponding 95% confidence intervals
| Parameter | Coh-whole^ | Coh-1.5 T^^ | Coh-3.0 T^^ |
|---|---|---|---|
| Accuracy | 0.65 (0.52–0.77) | 0.52 (0.32–0.71) | 0.76 (0.55–0.87) |
| Specificity | 0.64 (0.49–0.77) | 0.42 (0.22–0.66) | 0.75 (0.56–0.90) |
| Sensitivity | 0.70 (0.35–0.93) | 0.83 (0.36–0.99) | 0.50 (0.07–0.93) |
| NPV* | 0.91 (0.80–0.97) | 0.90 (0.59–0.98) | 0.92 (0.80–0.97) |
| PPV* | 0.28 (0.18–0.40) | 0.29 (0.20–0.41) | 0.22 (0.08–0.48) |
| Kappa statistics | 0.22 (0.00–0.43) | 0.15 (− 0.08 to 0.40) | 0.17 (− 0.18 to 0.51) |
^ whole cohort; ^^ patients that underwent 1.5 Tesla and 3.0 Tesla magnetic resonance imaging. *Negative and positive predictive values (NPV and PPV, respectively)